Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Pyridine | HCID 1049 | — |
| Reactant | Ethyl chloroformate | HCID 10928 | — |
| Reactant | 6-(4-fluorophenyl)-7-methyl-2,3-dihydro-1H-pyrrolizine | HCID 22335646 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | HCID 22557520 | HCID 22557520 | — |
Reaction Steps
The solution of 6-(4-fluorophenyl)-7-methyl-2,3-dihydro-1H-pyrrolizine (1.72 g, 8.0 mmol) in CH2Cl2 (55 ml) is firstly treated at 0° C. (ice bath) with pyridine (1.6 ml, 1.58 g, 20 mmol) and dropwise with the solution of ethyl chloroformate (2.1 g, 19.5 mmol) in CH2Cl2 (25 ml) (10 min). After a temperature rise to 3-6° C., the cooling agent is removed and the mixture is stirred for 1 h at RT, then heated to boiling temperature (36° C.) for 15 min. Then and after refluxing for a further hour, in each case 2 further portions of pyridine (each 0.8 ml, 10 mmol) and chloroformic acid (each 1.05 g, 10 mmol) are added dropwise and after a total of 3 h the reaction is terminated. The dark-colored batch solution is poured onto ice water (100 ml), stirred for 15 min and then the phases are separated. The water phase is extracted with CH2Cl2 (100 ml) and the combined organic phase is washed with water (50 ml), dried (Na2SO4 sicc.) and concentrated. As a residue, 2.69 g of dark oil (91.9% crude) remain which still contains residues of unreacted 6-(4-fluorophenyl)-7-methyl-2,3-dihydro-1H-pyrrolizine and was employed without further purification in the next stage.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06867211B2 |
|---|
| Source dataset | uspto-grants-2005_03 |
|---|
| ORD ID | ord-f90488b38ed9466695e3e9fa972de5eb |
|---|
| Source note | uspto-grants-2005_03 |
|---|